Assessment of safety and immunogenicity of MHC homozygous iPSC-derived CD34(+) hematopoietic progenitors in an NHP model

Administration of ex vivo expanded somatic myeloid progenitors has been explored as a way to facilitate a more rapid myeloid recovery and improve overall survival after myeloablation. Recent advances in induced pluripotent stem cell (iPSC) technologies have created alternative platforms for supplyin...

Descripción completa

Detalles Bibliográficos
Autores principales: D’Souza, Saritha S., Kumar, Akhilesh, Maufort, John, Weinfurter, Jason T., Raymond, Matthew, Strelchenko, Nick S., Perrin, Elizabeth, Coonen, Jennifer, Mejia, Andres, Simmons, Heather A., Torbett, Bruce E., Reynolds, Matthew, Thomson, James A., Slukvin, Igor I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Hematopoiesis and Stem Cells
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631690/
https://www.ncbi.nlm.nih.gov/pubmed/35404997
http://dx.doi.org/10.1182/bloodadvances.2022006984

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631690/
https://www.ncbi.nlm.nih.gov/pubmed/35404997
http://dx.doi.org/10.1182/bloodadvances.2022006984

Ejemplares similares